相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。HOW COVID UNLOCKED THE POWER OF RNA
Elie Dolgin
NATURE (2021)
TLR Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases
Marina Luchner et al.
PHARMACEUTICS (2021)
Non-viral COVID-19 vaccine delivery systems
Kyung Soo Park et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Targeting Toxins toward Tumors
Henrik Franzyk et al.
MOLECULES (2021)
Clinical development of retroviral replicating vector Toca 511 for gene therapy of cancer
Sara A. Collins et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2021)
Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology
Isaure Vanmeerbeek et al.
ONCOIMMUNOLOGY (2020)
Antitumor efficacy of cytosine deaminase-armed vaccinia virus plus 5-fluorocytosine in colorectal cancers
Yuedi Ding et al.
CANCER CELL INTERNATIONAL (2020)
Novel Histone-Based DNA Carrier Targeting Cancer-Associated Fibroblasts
Alexey Kuzmich et al.
POLYMERS (2020)
Searching for Promoters to Drive Stable and Long-Term Transgene Expression in Fibroblasts for Syngeneic Mouse Tumor Models
Dina Antonova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
An update on GM-CSF and its potential role in melanoma management
O. Robert Dillman
MELANOMA MANAGEMENT (2020)
A guide to cancer immunotherapy: from T cell basic science to clinical practice
Alex D. Waldman et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Oncolytic Virus-Based Cytokine Expression to Improve Immune Activity in Brain and Solid Tumors
Taylor M. Pearl et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
A Phase I-II Study Using Rexin-G Tumor-Targeted Retrovector Encoding a Dominant-Negative Cyclin G1 Inhibitor for Advanced Pancreatic Cancer
Sant P. Chawla et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
Prodrugs for targeted cancer therapy
Carla Souza et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2019)
Immunogenic cell death in a combined synergic gene- and immune-therapy against cancer
Benjamin Nayagom et al.
ONCOIMMUNOLOGY (2019)
The Pleiotropic Effects of the GM-CSF Rheostat on Myeloid Cell Differentiation and Function: More Than a Numbers Game
Yifan Zhan et al.
FRONTIERS IN IMMUNOLOGY (2019)
Unravelling Receptor and RGD Motif Dependence of Retargeted Adenoviral Vectors using Advanced Tumor Model Systems
M. Chernyavska et al.
SCIENTIFIC REPORTS (2019)
Recent advances in the development of gene delivery systems
Y. K. Sung et al.
BIOMATERIALS RESEARCH (2019)
Immunogenic Apoptosis as a Novel Tool for Anticancer Vaccine Development
Barbara Montico et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Compartmentalized Antimicrobial Defenses in Response to Flagellin
Aneesh Vijayan et al.
TRENDS IN MICROBIOLOGY (2018)
Evaluation of effectiveness of granulocyte-macrophage colony-stimulating factor therapy to cancer patients after chemotherapy: a meta-analysis
Wen-Liang Yu et al.
Oncotarget (2018)
Radiotherapy and immune response: the systemic effects of a local treatmentY
Heloisa de Andrade Carvalho et al.
CLINICS (2018)
Immunomodulation of the Tumor Microenvironment: Turn Foe Into Friend
Hanne Locy et al.
FRONTIERS IN IMMUNOLOGY (2018)
Talimogene Laherparepvec (T-VEC) and Other Oncolytic Viruses for the Treatment of Melanoma
Praveen K. Bommareddy et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2017)
Checkpoint immunotherapy: good for cancer therapy, bad for rheumatic diseases
Leonard Calabrese et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Intratumoral Delivery of Immunotherapy-Act Locally, Think Globally
M. Angela Aznar et al.
JOURNAL OF IMMUNOLOGY (2017)
Recent progress in GM-CSF-based cancer immunotherapy
Wan-Lun Yan et al.
IMMUNOTHERAPY (2017)
PCNA: A Constitutive Human Promoter for Gene Expression for Functional Studies and Therapeutic Applications
L. G. Kondratyeva et al.
MOLECULAR GENETICS MICROBIOLOGY AND VIROLOGY (2017)
A Novel DNA Vaccine Platform Enhances Neo-antigen-like T Cell Responses against WT1 to Break Tolerance and Induce Anti-tumor Immunity
Jewell N. Walters et al.
MOLECULAR THERAPY (2017)
Silencing of Foxp3 enhances the antitumor efficacy of GM-CSF genetically modified tumor cell vaccine against B16 melanoma
Antonio Miguel et al.
ONCOTARGETS AND THERAPY (2017)
Cytokines in immunogenic cell death: Applications for cancer immunotherapy
Anne Showalter et al.
CYTOKINE (2017)
Talimogene Laherparepvec: An Oncolytic Virus Therapy for Melanoma
Patricia A. Corrigan et al.
ANNALS OF PHARMACOTHERAPY (2017)
Novel immune check point inhibiting antibodies in cancer therapy-Opportunities and challenges
Yael Diesendruck et al.
DRUG RESISTANCE UPDATES (2017)
The Abscopal Effect of Radiation Therapy: What Is It and How Can We Use It in Breast Cancer?
Zishuo I. Hu et al.
CURRENT BREAST CANCER REPORTS (2017)
Immunogenic cell death in cancer and infectious disease
Lorenzo Galluzzi et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Molecular Pathways: Mechanism of Action for Talimogene Laherparepvec, a New Oncolytic Virus Immunotherapy
Frederick J. Kohlhapp et al.
CLINICAL CANCER RESEARCH (2016)
Combination cancer immunotherapies tailored to the tumour microenvironment
Mark J. Smyth et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Targeting GM-CSF in inflammatory diseases
Ian P. Wicks et al.
NATURE REVIEWS RHEUMATOLOGY (2016)
Progress and problems with the use of suicide genes for targeted cancer therapy
Zahra Karjoo et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Immune checkpoint inhibitors for cancer treatment
Junsik Park et al.
ARCHIVES OF PHARMACAL RESEARCH (2016)
Multidimensional complexity of cancer. Simple solutions are needed
E. D. Sverdlov
BIOCHEMISTRY-MOSCOW (2016)
Cancer immunotherapy: the beginning of the end of cancer?
Sofia Farkona et al.
BMC MEDICINE (2016)
Systematic review of the use of granulocyte-macrophage colony-stimulating factor in patients with advanced melanoma
Christoph Hoeller et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Oncolytic virus therapy: A new era of cancer treatment at dawn
Hiroshi Fukuhara et al.
CANCER SCIENCE (2016)
The Basis of Oncoimmunology
A. Karolina Palucka et al.
CELL (2016)
Antitumor efficacy of combined gene and radiotherapy in animals
O. A. Bezborodova et al.
DOKLADY BIOCHEMISTRY AND BIOPHYSICS (2016)
Gaining ground on a cure through synergy: combining checkpoint inhibitors with cancer vaccines
T. J. Vreeland et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2016)
Damage-associated molecular patterns in cancer: a double-edged sword
C. Hernandez et al.
ONCOGENE (2016)
Oncolytic viruses as immunotherapy: progress and remaining challenges
Laure Aurelian
ONCOTARGETS AND THERAPY (2016)
Local radiotherapy and GM-CSF in metastatic cancer: lessons from a proof of principle trial
Silvia C. Formenti et al.
OncoImmunology (2016)
Moving oncolytic viruses into the clinic: clinical-grade production purification and characterization of diverse oncolytic viruses
Guy Ungerechts et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2016)
Vaccines for established cancer: overcoming the challenges posed by immune evasion
Sjoerd H. van der Burg et al.
NATURE REVIEWS CANCER (2016)
Enhancement of Tumor-Targeted Delivery of Bacteria with Nitroglycerin Involving Augmentation of the EPR Effect
Jun Fang et al.
BACTERIAL THERAPY OF CANCER: METHODS AND PROTOCOLS (2016)
Immunogenic Human Papillomavirus Pseudovirus-Mediated Suicide-Gene Therapy for Bladder Cancer
Rim Hojeij et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Synergy of radiotherapy and PD-1 blockade in Kras-mutant lung cancer
Grit S. Herter-Sprie et al.
JCI INSIGHT (2016)
Stimulatory versus suppressive effects of GM-CSF on tumor progression in multiple cancer types
In-Sun Hong
EXPERIMENTAL AND MOLECULAR MEDICINE (2016)
Nitroreductase gene-directed enzyme prodrug therapy: insights and advances toward clinical utility
Elsie M. Williams et al.
BIOCHEMICAL JOURNAL (2015)
TLR5 Ligand-Secreting T Cells Reshape the Tumor Microenvironment and Enhance Antitumor Activity
Degui Geng et al.
CANCER RESEARCH (2015)
Defining Effective Combinations of Immune Checkpoint Blockade and Oncolytic Virotherapy
Juan J. Rojas et al.
CLINICAL CANCER RESEARCH (2015)
GM-CSF: An immune modulatory cytokine that can suppress autoimmunity
Palash Bhattacharya et al.
CYTOKINE (2015)
Arming oncolytic viruses to leverage antitumor immunity
Tanja D. de Gruijl et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2015)
Immune Checkpoint Blockade in Cancer Therapy
Michael A. Postow et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Therapeutic properties of a vector carrying the HSV thymidine kinase and GM-CSF genes and delivered as a complex with a cationic copolymer
Irina V. Alekseenko et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial
Encouse B. Golden et al.
LANCET ONCOLOGY (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
Immune Effects of Chemotherapy, Radiation, and Targeted Therapy and Opportunities for Combination With Immunotherapy
Jennifer A. Wargo et al.
SEMINARS IN ONCOLOGY (2015)
Oncolytic Adenovirus: Strategies and Insights for Vector Design and Immuno-Oncolytic Applications
Hanni Uusi-Kerttula et al.
VIRUSES-BASEL (2015)
The oncolytic peptide LTX-315 induces cell death and DAMP release by mitochondria distortion in human melanoma cells
Liv-Marie Eike et al.
ONCOTARGET (2015)
The Interplay of Immunotherapy and Chemotherapy: Harnessing Potential Synergies
Leisha A. Emens et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Novel Antitumor Strategy Utilizing a Plasmid Expressing a Mycobacterium tuberculosis Antigen as a Danger Signal to Block Immune Escape of Tumor Cells
Yoshiyuki Koyama et al.
PHARMACEUTICS (2015)
Gene-Directed Enzyme Prodrug Therapy
Jin Zhang et al.
AAPS JOURNAL (2015)
Producing GM-CSF: a unique T helper subset?
Dietmar Herndler-Brandstetter et al.
CELL RESEARCH (2014)
STAT5 programs a distinct subset of GM-CSF-producing T helper cells that is essential for autoimmune neuroinflammation
Wanqiang Sheng et al.
CELL RESEARCH (2014)
GM-CSF Production by Tumor Cells Is Associated with Improved Survival in Colorectal Cancer
Christian A. Nebiker et al.
CLINICAL CANCER RESEARCH (2014)
A Suicide Gene Therapy Combining the Improvement of Cyclophosphamide Tumor Cytotoxicity and the Development of an Anti-Tumor Immune Response
Walid Touati et al.
CURRENT GENE THERAPY (2014)
Application of central immunologic concepts to cancer: Helping T cells and B cells become intolerant of tumors
Colin C. Anderson
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
A Flagellin-Derived Toll-Like Receptor 5 Agonist Stimulates Cytotoxic Lymphocyte-Mediated Tumor Immunity
Nicholas D. Leigh et al.
PLOS ONE (2014)
Antigen-specific vaccines for cancer treatment
Maria Tagliamonte et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Danger signals - damaged-self recognition across the tree of life
Martin Heil et al.
FRONTIERS IN PLANT SCIENCE (2014)
A role for G-CSF and GM-CSF in nonmyeloid cancers
Alexander M. Aliper et al.
CANCER MEDICINE (2014)
Understanding MHC class I presentation of viral antigens by human dendritic cells as a basis for rational design of therapeutic vaccines
Nadine van Montfoort et al.
FRONTIERS IN IMMUNOLOGY (2014)
LTX-315 (Oncopore™) A short synthetic anticancer peptide and novel immunotherapeutic agent
Ketil Andre Camilio et al.
ONCOIMMUNOLOGY (2014)
Oncolytic viruses as anticancer vaccines
Norman Woller et al.
FRONTIERS IN ONCOLOGY (2014)
Oncolytic immunotherapy: dying the right way is a key to eliciting potent antitumor immunity
Zong Sheng Guo et al.
FRONTIERS IN ONCOLOGY (2014)
T cell responses: naive to memory and everything in between
Nathan D. Pennock et al.
ADVANCES IN PHYSIOLOGY EDUCATION (2013)
Immunogenic Cell Death in Cancer Therapy
Guido Kroemer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Microdistribution of MC1R-targeted polyplexes in murine melanoma tumor tissue
Mikhail O. Durymanov et al.
BIOMATERIALS (2013)
The innovative evolution of cancer gene and cellular therapies
P. Lam et al.
CANCER GENE THERAPY (2013)
A Multifunctional Chimeric Chaperone Serves as a Novel Immune Modulator Inducing Therapeutic Antitumor Immunity
Xiaofei Yu et al.
CANCER RESEARCH (2013)
Antiviral and Antitumor T-cell Immunity in Patients Treated with GM-CSF-Coding Oncolytic Adenovirus
Anna Kanerva et al.
CLINICAL CANCER RESEARCH (2013)
Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial
Manfred Westphal et al.
LANCET ONCOLOGY (2013)
Adenovirus Expressing Both Thymidine Kinase and Soluble PD1 Enhances Antitumor Immunity by Strengthening CD8 T-cell Response
Seung-Pil Shin et al.
MOLECULAR THERAPY (2013)
GM-CSF enhances tumor invasion by elevated MMP-2,-9, and-26 expression
Claudia M. Gutschalk et al.
CANCER MEDICINE (2013)
Regulation of dendritic cell development by GM-CSF: molecular control and implications for immune homeostasis and therapy
Lianne van de Laar et al.
BLOOD (2012)
Tumor-Derived Granulocyte-Macrophage Colony-Stimulating Factor Regulates Myeloid Inflammation and T Cell Immunity in Pancreatic Cancer
Lauren J. Bayne et al.
CANCER CELL (2012)
Suicide gene therapy in cancer: Where do we stand now?
Sonia Duarte et al.
CANCER LETTERS (2012)
Interleukin-1α controls allergic sensitization to inhaled house dust mite via the epithelial release of GM-CSF and IL-33
Monique A. M. Willart et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Enhanced antitumoral efficacy and immune response following conditionally replicative adenovirus containing constitutive HSF1 delivery to rodent tumors
Rong Fan et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Activity of the Upstream Component of Tandem TERT/Survivin Promoters Depends on Features of the Downstream Component
Irina V. Alekseenko et al.
PLOS ONE (2012)
Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression
Suzanne Ostrand-Rosenberg et al.
SEMINARS IN CANCER BIOLOGY (2012)
The convergence of radiation and immunogenic cell death signaling pathways
Encouse B. Golden et al.
FRONTIERS IN ONCOLOGY (2012)
Application of mRNA regulatory regions to improve tumor specificity of transgene expression
M. V. Shepelev et al.
CANCER GENE THERAPY (2011)
Oncolytic Adenoviruses for the Treatment of Human Cancer: Focus on Translational and Clinical Data
Sari Pesonen et al.
MOLECULAR PHARMACEUTICS (2011)
Thunder and Lightning: Immunotherapy and Oncolytic Viruses Collide
Alan Melcher et al.
MOLECULAR THERAPY (2011)
Use of GM-CSF as an adjuvant with cancer vaccines: beneficial or detrimental?
Kevin S. Clive et al.
EXPERT REVIEW OF VACCINES (2010)
Sitimagene ceradenovec: a gene-based drug for the treatment of operable high-grade glioma
Erik H. P. van Putten et al.
FUTURE ONCOLOGY (2010)
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
Martin A. Cheever et al.
CLINICAL CANCER RESEARCH (2009)
Prioritization of cancer antigens: keeping the target in sight
Joshua M. Lang et al.
EXPERT REVIEW OF VACCINES (2009)
A phase I trial of intratumoral administration of recombinant oncolytic adenovirus overexpressing HSP70 in advanced solid tumor patients
J-L Li et al.
GENE THERAPY (2009)
Polymer-based non-viral gene delivery as a concept for the treatment of cancer
Anna Halama et al.
PHARMACOLOGICAL REPORTS (2009)
The immune system - is it relevant to cancer development, progression and treatment?
R. J. Prestwich et al.
CLINICAL ONCOLOGY (2008)
Oncolytic viruses: a novel form of immunotherapy
Robin J. Prestwich et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2008)
Demystifying the development of dendritic cell subtypes, a little
Shalin H. Naik
IMMUNOLOGY AND CELL BIOLOGY (2008)
Characterisation of the expression and function of the GM-CSF receptor α-chain in mice
Marcela Rosas et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Suicide genes for cancer therapy
Daniel Portsmouth et al.
MOLECULAR ASPECTS OF MEDICINE (2007)
Antitumor activity of the TLR-5 ligand flagellin in mouse models of cancer
Lucia Sfondrini et al.
JOURNAL OF IMMUNOLOGY (2006)
Nonviral vectors for cancer gene therapy: Prospects for integrating vectors and combination therapies
JR Ohlfest et al.
CURRENT GENE THERAPY (2005)
Molecular identification of a danger signal that alerts the immune system to dying cells
Y Shi et al.
NATURE (2003)
Development of anti-tumor immunity against a non-immunogenic mammary carcinoma through in vivo somatic GM-CSF, IL-2, and HSVtk combination gene therapy
DG Brockstedt et al.
MOLECULAR THERAPY (2002)
The danger model: A renewed sense of self
P Matzinger
SCIENCE (2002)
Combined suicide and granulocyte-macrophage colony-stimulating factor gene therapy induces complete tumor regression and generates antitumor immunity
RK Jones et al.
CANCER GENE THERAPY (2000)
Efficacy of herpes simplex virus thymidine kinase in combination with cytokine gene therapy in an experimental metastatic breast cancer model
A Sen Majumdar et al.
CANCER GENE THERAPY (2000)
分享论文
